Centiva Capital, LP Bristol Myers Squibb CO Transaction History

Centiva Capital, LP

$5.63 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $655,934 - $782,710	13,530 Added 73.47%	31,945 $1.64 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $522,341 - $584,058	-9,023 Reduced 32.89%	18,415 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.28 Million - $1.42 Million	20,040 Added 270.88%	27,438 $1.75 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $1.12 Million - $1.27 Million	-17,043 Reduced 69.73%	7,398 $512,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1.1 Million - $1.3 Million	16,076 Added 192.18%	24,441 $1.76 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $996 - $589,285	-7,669 Reduced 47.83%	8,365 $594,000
Q2 2022 Aug 17, 2022	SELL	$72.62 - $79.98 $14.6 Million - $16.1 Million	-201,700 Reduced 92.64%	16,034 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $14.4 Million - $15.8 Million	197,624 Added 982.72%	217,734 $16.8 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $86,932 - $104,240	1,414 Added 7.56%	20,110 $1.47 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $802,996 - $940,606	13,571 Added 264.8%	18,696 $1.11 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $133,725 - $145,627	-2,160 Reduced 29.65%	5,125 $342,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $538,807 - $605,999	-9,080 Reduced 55.48%	7,285 $460,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $944,915 - $1.07 Million	16,365 New	16,365 $1.02 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $1.84 Million - $2.04 Million	-32,013 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $246,251 - $287,892	-4,492 Reduced 12.31%	32,013 $1.88 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $93,078 - $135,264	2,006 Added 5.81%	36,505 $2.04 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $1.49 Million - $1.94 Million	30,278 Added 717.32%	34,499 $2.21 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $852,876 - $1.01 Million	-19,941 Reduced 82.53%	4,221 $214,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $1.16 Million - $1.29 Million	-26,078 Reduced 51.91%	24,162 $1.1 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $1.29 Million - $1.53 Million	28,490 Added 130.99%	50,240 $2.4 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $1 Million - $1.3 Million	20,522 Added 1671.17%	21,750 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $67,773 - $76,443	1,228 New	1,228 $76,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account